Zymeworks Bc Inc.: Clinical Trials

1 trial sponsored by Zymeworks Bc Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Zymeworks Bc Inc.: new trials by email

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Personalized Medicine for Advanced Biliary Cancer Patients
Futibatinib, Ivosidenib, Zanidatamab - Biliary Tract Neoplasms
Phase 3RecruitingUNICANCER8002024-07-182026-05-19

Conditions studied

Biliary Tract Neoplasms (1)

Interventions

Cisplatin (1)  ·  Gemcitabine (1)  ·  Trastuzumab (1)  ·  binimetinib (1)  ·  encorafenib (1)  ·  futibatinib (1)  ·  ivosidenib (1)  ·  neratinib (1)  ·  niraparib (1)  ·  zanidatamab (1)

Countries

Belgium (1)  ·  France (1)  ·  United Kingdom (1)

Top investigators

Ivan Borbath, MD (1)  ·  John Bridgewater, MD (1)  ·  Juan W Valle (1)  ·  Julien Edeline, MD (1)  ·  Malka David, MD (1)